廣和中醫的三個療程如下:

第一階段:循序漸進停用西藥

西藥抑制皮膚疾病,因此,一旦您停止使用西藥,大多數情況肯定會惡化。因此,停用西藥是要表現出皮膚病的原始外觀,這通常是需要心理建設

因此在治療開始時不要停止使用西藥,無論是外用還是內用,然後在病情穩定後慢慢停止使用西藥。

從每天一次更改為每兩天一次。每天一次,可以最大程度地減少西藥的使用。

第二階段:中藥介入治療

經過第一階段後,並逐漸移至第二階段。此時您最需要的就是耐心!

皮膚疾病有很多干擾因素,因此在第一次就診時醫生要求改善飲食和充足睡眠

但是大多數人很難完全戒掉誘發皮膚病的食物,因此效果無法立竿見影。

或者,晚上工作超過12點才真正上床睡覺,而且身體沒有很好的休息時間,即使有效,也很慢。

病程越長,皮膚上累積的毒素越多,因此藥物也需要花費大量時間才能有效。

根據經驗,此時有80%的患者在沒有良好溝通的情況下放棄。真可惜,因為在此期間,症狀將開始改善。

第三階段:改善就在眼前

如果您可以堅持到這一階段,症狀將開始改善,皮膚過敏或是紅疹的範圍會開始減少。

皮膚的改善是顯而易見的,並且很難逆轉。有時你可能覺得血壓與皮膚無關,但是控制好血壓更好,反而皮膚自然會好轉,這也意味著血壓是皮膚炎的根本原因。

在我們的實際治癒的案例中,許多人都是漸漸捨棄西藥,轉向中醫治療,都獲得不錯的效果,而且復發的機率相當低

因此透過我們數十年的行醫經驗,讓你獲得改善各類皮膚炎的機會!
請立即尋求廣和中醫的協助,我們為您客製化專屬改善計畫!

廣和中醫診所位置:

廣和中醫深獲在地居民的一致推薦,也有民眾跨縣市前來求診

醫師叮嚀:病狀和體質因人而異,須找有經驗的中醫師才能對症下藥都能看到滿意的減重效果。

廣和中醫數十年的調理經驗,值得你的信賴。

WEDE46156FRE18EWCDW8CE

 

內容簡介

  自2003年以來,越來越多的合格境外機構投資者(QFII)開始進入中國市場。本書介紹了這些機構的背景資訊,以及他們如何為國內市場的發展做出貢獻,是投資者瞭解國外同行的重要參考資料。另外,作為這一領域的首部出版物,本書將為個人投資者和機構投資者(如QFII、私募基金、對沖基金和多頭基金)提供重要資訊,以助瞭解QFII從而制定自己的投資策略。同時,本書也將展示我們在下列專題的研究成果:

  合格境外機構投資者(QFII)最偏愛投資哪些行業?
  不同類型的合格境外機構投資者(QFII)又偏愛投資哪些行業?
  合格境外機構投資者(QFII)更偏愛各個行業內的哪些公司?
  書中收錄的對237家QFII公司的詳盡描述將幫助您逐一瞭解他們的背景和投資偏愛。

作者介紹

作者簡介

郭子中


  郭先生是前中國平安集團QFII部門主管,同來自美國、歐洲、中東、非洲以及亞太地區的QFII公司長期接觸,擁有同合格境外機構投資者(QFII)、合格境內機構投資者(QDII)、合格人民幣境外機構投資者(RQFII)、合格境外有限合夥人(QFLP)以及中國A股公司、中小板企業、私人企業和私募基金的密切聯繫。

關啟正

  關先生曾就雇於麥肯錫、瑞士銀行和摩根大通,並在摩根大通投資銀行部負責亞太區金融機構業務。
  他畢業於香港科技大學,獲得一等榮譽學士學位,並擁有香港大學金融學碩士學位。
  他亦持有金融風險管理師(FRM)和特許另類投資分析師(CAIA)證書。

目錄

List of Qualified Foreign Institutional Investor (QFII) 合格境外機構投資者
Foreword
About ChinaQFII Company Limited 中國橋金融網有限公司
Acknowledgement
Timeline of China Financial Market
Introduction of China Stock Market
China Stock Market Analysis
Overview of QFII Scheme
QFII and Private Equity / Deals in China
Ranking: Top Favorite Sector by QFII
Ranking: Top Favorite A shares by QFII
QFII Directory and Deals Review 1 - 237
Appendix A – List of Qualified Domestic Institutional Investor (QDII) 合格境內機構投資者
Appendix B – List of RMB Qualified Foreign Institutional Investor (RQFII) 人民幣合格境外投資者
Appendix C – China Companies / Organizations Visit
Appendix D – China Ping An Group Review

 

  QFII, which stands for Qualified Foreign Institutional Investors (合格境外机构投资者), has now been in existence for over 10 years. In 2002, the “Provisional Measures on Administration of Domestic Securities Investments of Qualified Foreign Institutional Investors” was promulgated by China Securities Regulatory Commission (“CSRC”) and People’s Bank of China, which marked the beginning of China’s QFII program.

  Since the inception of QFII, 237 financial institutions have received QFII license and US$46.4bn was given out by State Administration of Foreign Exchange (“SAFE”) as of August 2013. The approved quota contributes to around 1.5% of China stock market capitalization.

  As the foreign pioneers of China’s securities market and under the guidelines set out by CSRC, QFIIs have been investing mostly in stocks and bonds. However, some QFIIs have expanded their investment portfolio into different asset classes such as private equity and venture capital, while some acquire and form joint venture with Chinese companies. An example of this kind of transaction is the investment of Goldman Sachs and Morgan Stanley, two QFII license holders, in Ping An Insurance (Group) of China in June 1994.

  Ping An Insurance (Group) Company of China, Ltd ("Ping An") [2318.HK / 601318.CN] was established in 1988 in Shenzhen. The firm comprises three main business areas – Insurance, Investment and Banking.

  • Insurance – Life, Property & Casualty, Annuity, Health
  • Investment – Trust, Securities, Asset Management
  • Banking – Ping An Bank (Acquired from Shenzhen Development Bank)

  As the former Head of QFII Division in Ping An, I had the great pleasure to be part of this financial giant and experienced the ebbs and flows of the economic cycle with the Group. Ping An has also been prudently investing overseas from its first overseas investment in Fortis Investment in 2008. Along with its overseas investment and my role to develop QFII business, I had the opportunity to conduct roadshow in major cities across Europe, the U.S. and key cities in Asia, and to pitch Ping An’s strong capability in serving QFIIs.  

  Based on my experience and discussion with over 200 QFII key executives, they are not only looking for good investment opportunities within traditional asset classes in China, but also actively searching for alternative investments, for instance, private equity, venture capital, merger and acquisition, and joint venture. As far as private equity is concerned, roughly 74% of QFIIs have their in-house private equity team or become a limited partner of private equity funds. For example, OrbiMed Advisors LLC, which received a QFII license in October 2012, had invested in Beijing East Whale Imaging Technology in China in 2012. Meanwhile, some QFIIs, due to foreign restriction in establishing wholly-owned subsidiaries in China, have set up joint ventures with Chinese companies in order to expand their footprints in China. One example is the partnership between UBS and State Development Investment Corporation to establish UBS SDIC Fund Management in 2005.
Given the increasing demand of foreign institutions looking to invest in Chinese private market and a growing number of Chinese companies seeking foreign capital and partnership, I have founded “ChinaQFII Company Limited” with my partners to build up a truly unique and first platform to bridge the two sides – China and the World – hoping to facilitate private market investment and identify attractive investment opportunities.

  In order to let interested readers understand the history of QFII, and what kind of investment QFII license holders have made in China, our team has prepared the first publication “China Deals Review” to uncover some of the significant transactions for each QFII licensee. Our team wholeheartedly wishes you enjoy and benefit from reading this book as much as we enjoyed writing it.

William Kwok
Chief Executive Officer
ChinaQFII Company Limited

 

詳細資料

  • ISBN:9789888270101
  • 叢書系列:
  • 規格:軟精裝 / 268頁 / 15 x 21 x 1.6 cm / 普通級 / 全彩印刷 / 初版
  • 出版地:香港
  • 本書分類:> >

 

 

#每日一句論語#專欄的第 94 篇文章 大家好,歡迎打開#每日一句論語#專欄, 每天花5分鐘一起學論語,受益每一天! ... 或曰:「雍也仁而不佞。」子曰:「焉用佞?御人以口給,屢憎於人。不知其仁,焉用佞?」 【原文】 或曰:「雍也仁而不佞①。」子曰:「焉用佞?御人以囗給②,屢憎於人。不知其仁,焉用佞?」 【注釋】 ①雍:冉雍,字仲弓,孔子的學生。佞(nìng):能言善說、有囗才。 ②御:抵擋,這裡指爭辯頂嘴。囗給(jǐ):應對敏捷,嘴裡隨時都有供給的話語。 【譯文】 有人說:「冉雍這個人有仁德卻沒有囗才。」孔子說:「為什麼要有囗才呢?伶牙俐齒地和別人爭辯,常常被人討厭。我不知道他是否可稱得上仁,但為什麼要有囗才呢?」 【解讀】 前面篇章有提到過,孔子最反感的便是巧言令色之人。冉雍是孔子的學生,他性格仁慈厚道,不善言辭,所以有人以他沒有口才來責難他,而孔子則進行了反駁。 他認為,有沒有仁德和有沒有口才沒有必然聯繫,有仁德的人不需要巧言巧語,而沒有仁德的人就算口才再好又有什麼用呢?仁德的修養關鍵在於躬行,而言語表達則是次要的。因此,仁德的標準並不在於說而在於行。 溫馨提示 如果你喜歡本文,請分享到朋友圈,想要獲得更多信息,請關注我,謝謝。 #日更寫作#專欄 #每周一本書#專欄《每天一本書專欄·11月大盤點 | 陳小劍》#每日一句論語#專欄《《論語·公冶長篇第五》5.2:邦有道,不廢;邦無道,免於刑戮。》 《《論語·公冶長篇第五》5.3:君子哉若人!魯無君子者,斯焉取斯?》《《論語·公冶長篇第五》5.4:賜也何如?》#多元思維模型#專欄 《如何建立多元思維模型,提升自己的認知水平和人生效率?》 《如何運用「複利思維」投資你的人生,徹底拉開與別人的差距?》 《刻意練習,很多牛人都在使用的最高效訓練方法》 #思維偏誤#專欄《倖存者偏誤:成功是偶然的,失敗則是必然和普遍的》 《芒格:避免「司機知識」,成為擁有「真知識」的人!》 《確認偏誤:誰都別想說服我,除了我自己》 《自媒體時代:再小的個體,也有自己的品牌》 《把24小時變成48小時用的時間管理法》 《讓你事半功倍的目標管理方法》

 

 

 

 

 

文章來源取自於:

 

 

壹讀 https://read01.com/BJjR40M.html

博客來 https://www.books.com.tw/exep/assp.php/888words/products/0010624012

如有侵權,請來信告知,我們會立刻下架。

DMCA:dmca(at)kubonews.com

聯絡我們:contact(at)kubonews.com


西屯玫瑰斑/酒渣/酒糟/酒糟鼻推薦有效的中醫診所潭子毛孔角化症中醫診所推薦和平表皮分解性水皰症/大庖性表皮鬆懈症推薦有效的中醫診所北屯異位性皮膚炎止癢推薦有效的中醫診所
中壢網路評比不錯的皮膚科中醫診所 楊梅口腔潰瘍/口瘡治療有效的中醫診所 桃園八德雞眼中醫診所推薦南屯這間皮膚科中醫診所很大推 清水過敏性皮膚炎中醫診所推薦 東勢異位性皮膚炎止癢推薦有效的中醫診所Dcard皮膚科中醫診所推薦 太平皮下脂肪瘤中醫門診 平鎮落髮推薦有效的中醫診所北屯這間皮膚科中醫診所看診態度好 后里沙蚤病推薦有效的中醫診所 沙鹿傷口發炎推薦有效的中醫診所

arrow
arrow
    全站熱搜

    delgadh667p 發表在 痞客邦 留言(0) 人氣()